373 related articles for article (PubMed ID: 15026368)
1. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
2. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
3. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
4. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
Wu J; Liang Y; Nawaz Z; Hyder SM
Int J Oncol; 2005 Dec; 27(6):1647-59. PubMed ID: 16273221
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of progesterone-induced VEGF production in human breast cancer cells by the pure antiestrogen ICI 182,780.
Hyder SM; Stancel GM
Cancer Lett; 2002 Jul; 181(1):47-53. PubMed ID: 12430178
[TBL] [Abstract][Full Text] [Related]
6. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia reduces hormone responsiveness of human breast cancer cells.
Kurebayashi J; Otsuki T; Moriya T; Sonoo H
Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.
Rickard DJ; Waters KM; Ruesink TJ; Khosla S; Katzenellenbogen JA; Katzenellenbogen BS; Riggs BL; Spelsberg TC
J Bone Miner Res; 2002 Apr; 17(4):580-92. PubMed ID: 11918216
[TBL] [Abstract][Full Text] [Related]
10. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
McGowan EM; Clarke CL
Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
Hyder SM; Chiappetta C; Stancel GM
Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepatic progesterone and estrogen receptors in the female turtle, Chrysemys picta: relationship to vitellogenesis.
Custodia-Lora N; Novillo A; Callard IP
Gen Comp Endocrinol; 2004 Apr; 136(2):232-40. PubMed ID: 15028527
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular endothelial growth factor expression by estrogens and progestins.
Hyder SM; Huang JC; Nawaz Z; Boettger-Tong H; Mäkelä S; Chiappetta C; Stancel GM
Environ Health Perspect; 2000 Oct; 108 Suppl 5():785-90. PubMed ID: 11035983
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells.
Alban P; Hurd C; Dinda S; Khattree N; Moudgil VK
J Steroid Biochem Mol Biol; 2001 May; 77(2-3):135-41. PubMed ID: 11377979
[TBL] [Abstract][Full Text] [Related]
15. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
[TBL] [Abstract][Full Text] [Related]
16. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.
Pathiraja TN; Shetty PB; Jelinek J; He R; Hartmaier R; Margossian AL; Hilsenbeck SG; Issa JP; Oesterreich S
Clin Cancer Res; 2011 Jun; 17(12):4177-86. PubMed ID: 21459801
[TBL] [Abstract][Full Text] [Related]
18. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
19. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
20. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
